Introduction
As part of our interest in characterizing antiviral compounds from higher plants, we have investigated the constituents of Tripterygium wilfordii Hook. This plant has been used as an anticancer drug and an insecticide in China for hundreds of years, and recently as a drug for the treatment of rheumatoid arthritis and spondylitis in Chinese clinics (Juling el al., 1981) . Triptolide and tripdiolide were isolated from this plant as active antileukemic principles, but their modes of action are unknown (Kupchan el al., 1972) . During the studies on the sesquiterpene constituents of this genus, more than 20 compounds were isolated from T. wilfordii Hook fil. var. regelii Makino (Takaishi et al., 1987a (Takaishi et al., -c, 1988 (Takaishi et al., , 1990 (Takaishi et al., , 1991a . There is no report so far on any biological activity of these compounds. In this study, the antiviral activities of these sesquiterpenes were determined, and one of them, triptofordin C-2, was found to be active against herpes simplex virus type 1 (HSV-1) and human cytomegalovirus (HCMV). The possible mechanisms of its action are postulated.
Materials and methods

Chemicals
A-10, C-2, E-l and G-l, were isolated from T. wilfordii Hook fil. var. regelii Makino as described previously (Takaishi et al., 1991a-c) .
Cells and viruses
HeLa, human embryonic lung (HEL), Vero and MDCK cells were grown in Eagle minimum essential medium (MEM) supplemented with 5% fetal bovine serum (FBS). HSV-1 (HF strain) was grown on HeLa cells, human cytomegalovirus (HCMV) (Towne strain) on HEL cells, measles virus (Toyoshima strain), poliovirus type 1 (Sabin strain) and coxsackievirus type Bl (Conn-5 strain) on Vero cells and influenza A virus (NWS strain, H1N1) on MDCK cells, respectively.
Cytotoxicity
For cell growth inhibition studies, HeLa, Vero and HEL cells were inoculated in 24-well plates at an initial density of about 1 x 10 4 cells per well. After the cells had been incubated for 8 h at 37°C, each compound was added and both HeLa and Vero cells or HEL cells were incubated for a further 3 or 5 days, respectively. Viable cell yield was determined by the trypan blue exclusion test. The inhibition data were plotted as dose-response curves, from which the 50% inhibitory dose (ID50) was obtained. In some experiments, HeLa cells were cultured for 3 days in the presence of triptofordin C-2, and thereafter incubated in drug-free medium for an additional 7 days.
Antiviral activity
The methods for antiviral assay have been described previously (Hayashi, Hayashi & Morita, 1992) . Cell monolayers were infected with virus at 0.1 plaque-forming unit (pfu) per cell for 1 h at room temperature and refed with maintenance medium (MEM plus 2% FBS) containing various concentrations of drug. Virus yield was determined by plaque assay at 1-day incubation for HSV-1, poliovirus and coxsackievirus, and at 5-days incubation for HCMV. The 50% inhibition dose for antiviral activity (ED50) was obtained from dose-response curves.
Effect on virus adsorption to cells
The assay of virus adsorption was performed according to the methods reported previously (Hayashi et al., 1993) . Briefly, HeLa cell monolayers were pretreated with triptofordin C-2 for 3 h at 37°C. After being washed with phosphate-buffered saline (PBS) (pH 7.2), the cells were inoculated with HSV-1 at 1 pfu per cell for 1 h at 37°C. The inocula were recovered, and the unadsorbed viruses in these samples were titrated by plaque assay.
Inhibition of virus penetration
The procedures for virus penetration assay have been described previously (Hayashi et al., 1992) . Briefly, HeLa cell monolayers were inoculated with HSV-1 and incubated at 4°C for adsorption in the absence of triptofordin C-2. After 1 h, the cultures were refed with triptofordin C-2-containing medium and shifted to 37°C to allow penetration into cells. At 30 min to 6 h incubation, extracellular viruses were inactivated by treatment with citrate buffer (pH 3.0) for 1 min. The monolayers were overlaid with 0.5% methylcellulose and incubated for 2 days to be plaque-assayed.
Virus inactivation
To test possible virucidal activity, equal volumes (1 mL) of virus stocks (2 x 10 6 pfu/mL) and MEM containing increasing concentrations of triptofordin C-2 were mixed and incubated for 1, 3 or 6 h at 37°C. Thereafter, the mixtures were diluted 10-fold serially and titrated by plaque assay.
SDS-PAGE analysis of radiolabelled proteins
HeLa cells were mock-infected or infected with HSV-1 at lOpfu per cell, and radiolabelled at the times indicated. After replenishing the monolayers with methionine-free MEM (Flow Laboratories, Irvine, UK), 10/iCi of Tran "S-label (> 1000 Ci/mmol; ICN Biomedicals, Inc., Costa Mesa, CA, USA) was added per 35 mm dish and incubated at 37°C. For labelling of immediate early proteins of HSV-1, HeLa cells were treated with 50 mg/L cycloheximide 1 h before virus infection, cultured at 37°C for 2 h postinfection (pi) in the presence of cycloheximide, then washed with PBS to remove cycloheximide, and incubated for a further hour with the medium containing Tran 35 S-label in the presence of 5 mg/L actinomycin D. triptofordin C-2 was added during incubation with cycloheximide or actinomycin D. Mock-infected and infected cells were harvested and extracted with lysis buffer (0.05 M Tris-HCl, pH 7.0, 0.15 M NaCl, 1% SDS, 1% Triton X-100). A portion of the cell lysates was treated with rabbit anti-HSV-1 serum prepared in our laboratory (Hayashi et al., 1992) and protein A-Sepharose 4FF (Pharmacia LKB Biotechnology, Uppsala, Sweden). The immunoprecipitates and the cell lysates were analyzed by 8% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Gels were soaked in 1 M sodium salicylate for 30 min, and X-ray films were exposed to the dried gels (Sambrook, Fritsch & Maniatis, 1989) .
Analysis of antiviral synergism
The combined activity of triptofordin C-2 and acyclovir against HSV-1 was assessed by the criteria reported by Spector, Tyndall & Kelley (1982) . When T, A, TA and C are the mean virus yields in the presence of triptofordin C-2, acyclovir, both triptofordin C-2 and acyclovir, and in the absence of drugs (control), respectively, the combination index (CI) is defined as follows:
The interaction between triptofordin C-2 and acyclovir is taken as additive if the CI is within 2SE (standard error) of zero (i.e., 0-2SE < CI < 0 + 2SE), as synergistic if the CI is more than 2SE greater than zero (CI > 0 + 2SE), or as antagonistic if the CI is more than 2SE less than zero (CI < 0 -2SE). SE was calculated from the value of triplicate experiments.
Results
Effects of sesquiterpenes on HeLa cell growth and HSV-1 replication
The cytotoxicity of sesquiterpenes was determined using uninfected HeLa cells to obtain the 50% inhibitory dose (ID50). The 50% effective dose (ED*,) against HSV-1 was also determined for each compound. When the in-vitro selectivity indices were calculated by dividing the ID50 by the EDJO, the values for all compounds but triptofordin C-2 were less than 10 (data not shown). Triptofordin C-2 showed the most potent inhibition on HSV-1 replication with a selectivity index of 24 (Table I) . Thus, the following experiments were carried out on triptofordin C-2. The growth of HeLa cells in the presence of triptofordin C-2 at various concentrations and in the drug-free conditions thereafter was monitored. As shown in Figure 1 , triptofordin C-2 exerted relatively low cytotoxicity to rapidly growing cells. The cells continued to grow dose-dependently in the presence of triptofordin C-2 less than 100 mg/L, but appeared to cease growing during 1 to 3 days of incubation at a higher concentration of 250 mg/L. When triptofordin C-2 was removed from medium after 3 days of incubation, the cells began to grow rapidly to the level of drug-free control cultures, and even in the cultures treated with 100 mg/L of triptofordin C-2 the cell growth recovered to the level of the control culture by 7 days after drug removal.
Antiviral spectrum of triptofordin C-2
Vero and HEL cells were also treated with triptofordin C-2. Calculated ID» values against Vero and HEL cells were 76 and 66 mg/L, respectively. Under the experimental conditions where triptofordin C-2 was added to the medium immediately after virus infection, the compound suppressed the replication of HSV-1 and HCMV (Table I) . However, no activity was found against poliovirus and coxsackievirus. HSV-1 was the most susceptible virus to triptofordin C-2 among the viruses tested.
Effects of triptofordin C-2 on virus adsorption and penetration
The effect of triptofordin C-2 on adsorption was determined by inhibition of HSV-1 binding to host cells pretreated with various concentrations of the compound. The number of viruses that did not bind to HeLa cells was assayed by plaque titration. At concentrations of 4-100 mg/L, triptofordin C-2 showed no inhibition of virus adsorption to cell membranes (data not shown).
Virus penetration into cells is also one of the indicator of antiviral targets. Thus, in order to investigate the effect of triptofordin C-2 on penetration of HSV-1, a penetration assay was performed according to the procedures based on the resistance of internalised viruses to inactivation by acid treatment (Huang & Wagner, 1964; Highlander et al., 1987) . Approximately 95% of the attached viruses penetrated the host cells within 30 min. The presence of triptofordin C-2 during virus penetration resulted in no dose-dependent inhibition of virus penetration when the compound was added at concentrations up to 100 mg/L. These results suggest that triptofordin C-2 does not interfere with fusion between virus envelope and cell membrane.
Direct virus inactivation by triptofordin C-2
The possibility that triptofordin C-2 directly interferes with virus infectivity, thus preventing adsorption of virus particles to host cells, was investigated. Several viruses and triptofordin C-2 were mixed and incubated for 3 h at 37°C. As shown in Table II , moderate dose-dependent virucidal effects of triptofordin C-2 against HSV-1, HCMV, influenza A virus and measles virus were observed. At the highest concentration tested (50 mg/L) the residual infectivity of these viruses was approximately 30-50% when compared with control preparations. Poliovirus and coxsackievirus were not affected by the compound.
This time-dependent inactivation of HSV-1 by triptofordin C-2 was studied further (Table III) . Triptofordin C-2 inactivated the virus with extension of the incubation time from 1 h to 6 h. Even at a low concentration of 2 mg/L, HSV-1 was inactivated to 34% when compared with control. Virus was incubated for 3 h with triptofordin C-2.
•Each value is the remaining virus titre expressed as the percentage of untreated control.
Effect of triptofordin C-2 on protein synthesis
At first, the effect of triptofordin C-2 on host cell protein synthesis was studied by incubation of uninfected HeLa cells with the compound for 4 h. As shown in Figure 2 (a), triptofordin C-2 did not inhibit cellular protein synthesis at concentrations of 20 and 100 mg/L. On the other hand, virus-infected cells were affected by triptofordin C-2. When HeLa cells were infected with HSV-1 and pulse-labelled during 0-4 h pi, the synthesis of virus-specific proteins was inhibited by adding triptofordin C-2 (Figure 2(b) ). However, the compound did not inhibit protein synthesis when it was added during 4-8 h pi. These results indicate that triptofordin C-2 interferes with the early step of virus replication. To clarify the effect of triptofordin C-2 on the viral immediate early (IE) proteins, IE proteins were detected by incubation of infected cells in the presence of actinomycin D after release from a cycloheximide block. As shown in Figure 2 (c), partial suppression of the expression of IE proteins was observed when triptofordin C-2 was present during the translation period (2-3 h postinfection), but not during the transcription period ( -2-2 h postinfection).
Interaction between triptofordin C-2 and acyclovir
To determine if there was antiviral synergism between triptofordin C-2 and acyclovir, HSV-infected cells were incubated in medium containing different concentrations of Table ID triptofordin C-2 and/or acyclovir. From the results obtained as virus yield, synergism was evaluated using the criteria reported by Spector et al. (1982) . As shown in Table IV , triptofordin C-2 at 4-100 mg/L did not potentiate acyclovir at 0.2, 1, 5 and 25 mg/L, while an additive effect was seen by the combination of triptofordin C-2 and acyclovir.
Discussion
Triptofordin C-2 was the most potent inhibitor of the sesquiterpenes tested, which were isolated from T. wilfordii Hook fil. var. regelii Makino. In order to elucidate the mode of action of the inhibition of virus replication, the effects of triptofordin C-2 were studied under various conditions. Triptofordin C-2 exerted its antiviral activity on enveloped viruses including HSV-1 and HCMV, but not on unenveloped viruses including poliovirus and coxsackievirus. Virus inactivation experiments showed that triptofordin C-2 had moderate virucidal effect against several enveloped viruses including HSV-1, HCMV, influenza A virus and measles virus, but not against unenveloped viruses. Attachment of HSV-1 to host cells and penetration thereafter were unaffected by triptofordin C-2. These results indicate that antiviral effects of triptofordin C-2 on enveloped viruses might be attributed at least in part to its direct inactivation of virus particles. The treatment of mock-infected cells with triptofordin C-2 had no effect on cellular protein synthesis, whereas the agent inhibited translation in HSV-infected cells. Thus, one interpretation of these results is that the protein-synthesizing machinery of infected cells is more sensitive to triptofordin C-2 than that of uninfected cells. Studies on the time of addition of triptofordin C-2 to HSV-infected cells indicate that the compound suppressed protein synthesis at earlier steps of virus replication. However, it did not inhibit synthesis when added at 4 to 8 h postinfection, when proteins of the /? and y groups are synthesized (Honess & Roizman, 1974; Roizman & Sears, 1990) . When the effect of triptofordin C-2 on the expression of IE (a) genes was examined, which, by definition, are transcribed in infected cells in the absence of viral protein synthesis, translation of the IE transcripts was suppressed by the compound, while transcription of the IE genes was not affected. This suggests that triptofordin C-2 blocks a step of translation rather than that of transcription in the early events of virus replication. Some antiviral flavones are known to block RNA synthesis (Ishitsuka et al., 1982; Castrillo, Vander Berghe & Carrasco, 1986; Hayashi et al., 1993) . Thus, a sesquiterpene, triptofordin C-2, is different from these flavones in its mechanism of antiviral action.
By combining antiviral agents with different mechanisms of action, synergistic effects may reduce the possibility of the emergence of drug-resistant virus strains and reduced dosage may reduce the cytotoxicities of the agents. In herpes simplex virus infections, resistant strains of HSV against acyclovir have been frequently detected (Coen & Schaffer, 1980 , Field & Coen, 1986 . In this study, we assessed the synergism between acyclovir and triptofordin C-2 against HSV-1. However, no synergism was found, but an additive effect was seen.
In conclusion, triptofordin C-2 is an inhibitor of HSV-1 replication at concentrations that have little or no effect on the growth of host cells. The compound showed efficacy in the inactivation of virus.
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